SLC16A1 and cancer: Given that miR-29 is frequently lost in cancer and has been reported to negatively regulates monocarboxylate transporter 1 (MCT1), a lactate transporter [183,184] it has been tempted a novel approach that involves the use of miR-29 mimic (MRG-201).